Literature DB >> 6604127

Evidence for two distinct classes of murine B cell growth factors with activities in different functional assays.

S L Swain, M Howard, J Kappler, P Marrack, J Watson, R Booth, G D Wetzel, R W Dutton.   

Abstract

Several previously described B cell growth factor (BCGF) activities from a number of mouse monoclonal T cell sources were compared in different functional assays. The results indicate that there are two distinct classes of BCGF defined by functional activity and source. BCGF I, whose prototype is (EL4)BCGF, synergized with anti-Ig in the proliferation of normal splenic B cells but had no activity when dextran sulfate (DXS), rather than anti-Ig, was used to costimulate the same source of B cells. BCGF I also failed to directly stimulate BCL1 tumor B cells. In contrast, BCGF II, whose prototype is (DL)BCGF, showed a reciprocal pattern of activity. BCGF II failed to synergize with anti-Ig-costimulated normal B cells to give good proliferative responses. Sources of BCGF II also directly stimulated (no anti-Ig or DXS added) B cells of the BCL1 tumor-carrying mice. These results suggest that the two BCGF may have activity on two subsets of B cells that respond differentially to induction with the two polyclonal B cell activators, anti-Ig and DXS. The possibilities that these different patterns of response occur in separate lineages of B cells and/or in B cells in different states of differentiation is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6604127      PMCID: PMC2187105          DOI: 10.1084/jem.158.3.822

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  37 in total

1.  Spontaneous murine B-cell leukaemia.

Authors:  S Slavin; S Strober
Journal:  Nature       Date:  1978-04-13       Impact factor: 49.962

2.  Selective triggering of B cell subpopulations by mitogens.

Authors:  E Gronowicz; A Coutinho
Journal:  Eur J Immunol       Date:  1974-11       Impact factor: 5.532

3.  Activation of murine B lymphocytes. III. Stimulation of B lymphocyte clonal growth with lipopolysaccharide and dextran sulfate.

Authors:  G D Wetzel; J R Kettman
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

4.  Identification of a T cell-derived b cell growth factor distinct from interleukin 2.

Authors:  M Howard; J Farrar; M Hilfiker; B Johnson; K Takatsu; T Hamaoka; W E Paul
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

5.  Induction of proliferation and Ig production in human B leukemic cells by anti-immunoglobulins and T cell factors.

Authors:  K Yoshizaki; T Nakagawa; T Kaieda; A Muraguchi; Y Yamamura; T Kishimoto
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

6.  Characterization of a spontaneous murine B cell leukemia (BCL1). II. Tumor cell proliferation and IgM secretion after stimulation by LPS.

Authors:  M R Knapp; E Severinson-Gronowicz; J Schröder; S Strober
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

7.  Defective colony formation by B lymphocytes from CBA/N and C3H/HeJ mice.

Authors:  P W Kincade
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

8.  Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines.

Authors:  J Watson; S Gillis; J Marbrook; D Mochizuki; K A Smith
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

9.  B-cell differentiation in the CBA/N mouse. I. Slower maturation of mitogen and antigen-responsive B cells in mice expressing an X-linked defect.

Authors:  C A Whitlock; J D Watson
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

10.  Concanavalin A-inducible, interleukin-2-producing T cell hybridoma.

Authors:  L Harwell; B Skidmore; P Marrack; J Kappler
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

View more
  50 in total

Review 1.  The immunological synapse.

Authors:  Michael L Dustin
Journal:  Cancer Immunol Res       Date:  2014-11       Impact factor: 11.151

2.  Differential mechanism for differentiation into immunoglobulin-secreting cells in human resting B lymphocyte subsets isolated on the basis of cell density.

Authors:  N Suzuki; Y Ueda; T Sakane
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

Review 3.  The interleukins in acquired disease.

Authors:  M Malkovský; P M Sondel; W Strober; A G Dalgleish
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

4.  Production of a monoclonal antibody useful in the molecular characterization of murine T-cell-replacing factor/B-cell growth factor II.

Authors:  N Harada; T Takahashi; M Matsumoto; T Kinashi; J Ohara; Y Kikuchi; N Koyama; E Severinson; Y Yaoita; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

Review 5.  Regulation of IgA synthesis and immune response by T cells and interleukins.

Authors:  J R McGhee; J Mestecky; C O Elson; H Kiyono
Journal:  J Clin Immunol       Date:  1989-05       Impact factor: 8.317

6.  Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50.

Authors:  E A Clark; J A Ledbetter
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

7.  Models and mechanisms for signal transduction in B cells.

Authors:  C A Pennell; D W Scott
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

8.  B cell growth factor activity in supernatants of MRL-lpr/lpr derived T cell hybridomas.

Authors:  U Schauer
Journal:  Clin Exp Immunol       Date:  1988-05       Impact factor: 4.330

9.  Polyclonal immunoglobulin secretion in patients with common variable immunodeficiency using monoclonal B cell differentiation factors.

Authors:  L Mayer; S M Fu; C Cunningham-Rundles; H G Kunkel
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

10.  Evidence for an intracellular precursor for human B-cell growth factor.

Authors:  C G Sahasrabuddhe; J Morgan; S Sharma; S Mehta; B Martin; D Wright; A Maizel
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.